Evidence map›Paper›PMID 40933565›Full record

ArticleFrontiers in medicine2025

Combined role of thromboelastography and coagulation indicators in predicting thromboembolism risk in cancer patients.

Liqiu Huang, Wei Dong, Xiaojie Hu, Yu Wang, Lina Zhang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Liqiu HuangDepartment of Laboratory, Tangshan Central Hospital, Tangshan, Hebei, China.
Wei DongDepartment of Internal Medicine, Tangshan Fengnan District Hospital, Tangshan, Hebei, China.
Xiaojie HuDepartment of Emergency, Affiliated Hospital of North China University of Science and Technology, Tangshan, Hebei, China.
Yu WangDepartment of Laboratory, Tangshan Central Hospital, Tangshan, Hebei, China.
Lina ZhangDepartment of Laboratory, Tangshan Central Hospital, Tangshan, Hebei, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Exploring the application value of thromboelastography (TEG) and four coagulation indicators in the risk assessment of thromboembolism (TE) in cancer patients. Methods: Retrospectively analyzed the clinical data of 160 cancer patients. Among them, 45 patients experienced thromboembolism (TE group) and 115 patients did not experience thromboembolism (non-TE group). We analyzed the levels of TEG and coagulation indicators in the two groups of patients and the risk factors for TE in cancer patients. Results: The Angle and MA of the thromboembolic group were significantly higher than those of the non-TE group, whereas K and R were significantly lower than those of the non-TE group ( Conclusions: TEG and coagulation index level detection have high application values in the risk assessment of TE in cancer patients.

Indexed as

cancer patientscoagulation indicatorsriskthromboelastographythromboembolism

Identifiers

PMID40933565
PMCPMC12417428

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.